ARTICLE | Clinical News
ChemoFx Assay diagnostic data
March 3, 2014 8:00 AM UTC
An observational study in 276 patients with stage III/IV ovarian, fallopian or peritoneal cancer who received first-line therapy of carboplatin and paclitaxel showed that median PFS was significantly ...